Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Belgium

European Research Council grant · Running

PERTURB-Flow In vivo PERTURB-Flow: high-throughput single-cell perturbation screening for macrophage target discovery

Coordinator
Vrije Universiteit Brussel, Belgium
Runs
1 April 2026 to 30 September 2027
Status
Running
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101291741

What the project is doing

In the project's own words, from its summary on CORDIS.

This project aims to deliver proof-of-concept for in vivo PERTURB-Flow, a breakthrough technology for the systematic discovery of therapeutic targets in macrophages. The proof-of-concept will focus on microglia, the brain’s resident macrophages, both in homeostatic and disease conditions. In parallel, we will engage industrial partners and perform business development, patent and freedom-to-operate analyses, laying the groundwork for valorization and spin-off development.

Together, these activities will establish a powerful platform that may move the macrophage field beyond its current scarcity of targets, providing a scalable pipeline for in vivo–validated therapeutic discovery.

Who is involved

OrganisationCityCountryRole
Vrije Universiteit BrusselBruxelles / BrusselBelgiumCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI